Advisory Board and Editors Pharmacology
Dirk W. Lachenmeier
Dr. Dirk Lachenmeier is a state-certified food chemist, toxicologist, head of the department of plant-based foods and co-head of the nuclear magnetic resonance laboratory at Chemical and Veterinary Investigation Agency, Karlsruhe, Germany, which is a governmental food, medicine and alcohol control authority.
He earned his PhD in Forensic Toxicology from the University of Bonn.
Brittany N Lasseigne
Brittany N. Lasseigne, PhD is an Assistant Professor of Cell, Developmental and Integrative Biology at The University of Alabama at Birmingham School of Medicine. She trained in Biotechnology, Science, and Engineering at Mississippi State University (B.S.) and the University of Alabama in Huntsville (Ph.D.) and completed a postdoctoral fellowship in genetics and genomics at the HudsonAlpha Institute for Biotechnology.
Her lab develops and applies genomic- and data-driven strategies (including single-cell and long-read sequencing) to discover biological signatures that might be used to improve patient care and provide insight into the cellular and molecular processes contributing to disease, especially for diseases impacting the brain and/or kidney. Their recent work includes prioritizing drug repurposing candidates for cancers and polycystic kidney disease, evaluating preclinical models and cross-species transcriptomic signatures to improve disease modeling, and applying single-cell and long-read technologies to neurological disease tissues to understand the role that context plays in disease etiology, progression, and treatment.
The Lasseigne Lab is currently focused on integrating genomics data, functional annotations, and patient information with machine learning and regulatory network approaches across diseases that impact the brain or kidney to discover novel mechanisms in disease etiology and progression, identify genome-driven therapeutic targets and opportunities for drug repositioning and repurposing, determine clinically-relevant biomarkers, and understand how cellular context contributes to these diseases. Collectively, these distinct projects all apply genetics and genomics to human diseases and build tools to accelerate future research. Their lab also develops data science software and analytical pipelines that are open-source, well-documented, and hosted by third-party code distributors, critical for facilitating reproducibility and enabling the research community to use the methods they develop.
Florian Lesage
Florian Lesage is senior research director at INSERM (French National Health Institute). He is a molecular biologist with extensive experience in ion channel cloning, expression and characterization, in particular in the neurosensory systems. He has authored 15 international patents and >120 publications that have received more than 15,000 citations (http://scholar.google.fr/citations?user=4RXbfuMAAAAJ&hl=fr&oi=ao).
Florian Lesage is the director of the Laboratoire d'Excellence "Ion Channel Science and Therapeutics" (LabEx ICST, www.labex-icst.fr/en).
Dongliang Liu
Dr. Dongliang Liu is a Postdoctoral Associate in the Department of Surgery at the Baylor College of Medicine. His research interests include: Cancer therapy, especially for pancreatic cancer immunotherapy; Chimeric virus-like particles (VLP) vaccine, especially for cancer vaccines; Novel antibiotics development including antimicrobial peptides; Epitomics and multi-epitope peptide vaccine development for pathogenic viruses.
Yoshinori Marunaka
Prof. Marunaka is the President and the Representative Director, Director of Clinical, and Director of Medical Research Institute, Kyoto Industrial Health Association; Professor, Research Organization of Science and Technology, Ritsumeikan University; Professor Emeritus, Kyoto Prefectural University of Medicine; Former President, Physiological Society of Japan. Former President, International Society of Cancer Metabolism. MD (1979), PhD (1985), Kyoto Prefectural University of Medicine; National License of Physician and Surgeon, Japan (1979). He was Professor and Chairperson, Departments of Molecular Cell Physiology and Bio-Ionomics, Kyoto Prefectural University of Medicine, Japan, and Director and Professor, Japan Institute for Food Education and Health, St. Agnes’ University. He was awarded “Vebleo Nanomedicine Scientist Award” (Sweden), “Marco Polo della Scienza Italiana” (Italy), The Premier's Research Excellence Award (Canada), Scholar Award (Medical Research Council of Canada) and Research Award from National Kidney Foundation of USA. He has obtained more than 60 research grants, published more than 270 peer reviewed articles, and provided more than 30 invited plenary lectures at international congresses and research conferences. h-index 47, i10-index 190, Citation 7498
Fabrizio Mattei
Dr. Fabrizio Mattei graduated from University “La Sapienza” in Rome and completed his specialization in biotechnologies and oncology at the same university. In 2000, he became a fellow at the Edward Jenner Institute for Vaccine Research in David Tough's laboratory (Newbury, U.K.), where he acquired experience in the field of dendritic cell immunology. He is currently a Researcher, Group Leader and Principal Investigator at the Istituto Superiore di Sanità (Rome, Italy), where he has focused on the molecular interactions between dendritic cells and type I Interferons signalling.
His current research is aimed at understanding the role of Interferons signalling and IL-33 in the interface between tumor and immune system in both mouse and human models. Furthermore, he is also conducting research aimed at investigating on crosstalk between immune system and cancer by Cell-on-Chip devices. In addition, Dr. Mattei is developing a multidisciplinary laboratory network focused at the realization of Organ-On-Chip platforms, useful to mimic and study human diseases and cancer.
Ipsita Mohanty
Dr. Ipsita Mohanty is a Research Associate II at the Children's Hospital of Philadelphia Research Institute
Her current research focuses on investigating the molecular mechanisms of nitric oxide signaling pathway at the proteome levels using multipronged approach of mouse genetics, ex vivo mechanistic functional study as well as high throughput mass spectroscopy techniques.
Dr. Mohanty has expertise in pharmacology, physiology, and proteomics with emphasis in intracellular signal transduction and GPCR signaling directed towards designing therapeutic strategies for cardiovascular disorders. Technical cognizance encompasses fields of Smooth Muscle pharmacology, Integrative Physiology, Contraction Physiology, Proteomics, Biochemistry, Molecular Biology, Bioinformatic Data Analysis (and related softwares) for Mass Spectrometry data and In-Vivo skills.
Rafael J Najmanovich
Associate Professor, Systems & Structural Computational Pharmacology. University of Montreal, Canada. Postdoc EMBL-EBI. PhD Physics & Biology, Weizmann Institute of Science, Israel. MSc Statistical Biological Physics & BSc. Molecular Sciences, University of São Paulo, Brazil.
Giribabu Nelli
Dr. Giribabu Nelli is a Senior Lecturer within the Department of Physiology at Universiti Malaya.
Hi primary research areas include, Reproductive Biology, Diabetes and their complications, and Natural Products Research.
Jorddy Neves Cruz
Dr. Jorddy Neves Cruz is researcher in Federal University of Pará and Paraense Emílio Goeldi Museum. His research focuses on (1) Medicinal Chemistry, with a particular emphasis on natural products and drug discovery/ design; (2) Extraction and characterization of compounds of natural origin (isolated compounds, essential oils, and fixed oils); (3) molecular modeling approaches and (4) evaluation of biological activities and pharmacological potential of natural compounds.
Ho Leung Ng
Principal Scientist, Atomwise. Adjunct associate professor of biochemistry and biophysics at Kansas State University. Research in computational/AI and structure-based drug design, biophotonics, machine learning for chemistry and drug discovery, protein crystallography.
Cristina W Nogueira
Associate professor at Federal University of Santa Maria, Brazil. My current research interests center around the pharmacology and toxicology of organochalcogen compounds. Scopus researcher award/2010.